The Role of G Protein β3 Subunit Polymorphisms C825T, C1429T, and G5177A in Turkish Subjects with Essential Hypertension

REFERENCES

• Weinstein LS, Chen M, Xie T, Liu J. Genetic diseases associated with heterotrimeric G proteins. Trends Pharmacol Sci 2006; 27:260–266.
   PubMed Web of Science ®Google Scholar
• Tanira MO, Al Balushi KA. Genetic variations related to hypertension. J Hum Hypertens 2005;19:7–19.
   PubMed Web of Science ®Google Scholar
• Williams SM, Addy JH, Phillips JA III, Dai M, Kpodonu J, Afful J, Jackson H, Joseph K, Eason F, Murray MM, Epperson P, Aduonum A, Wong LJ, Jose PA, Felder RA. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000;36:2–6.
   PubMed Web of Science ®Google Scholar
• Cooper R, Rotimi C. Hypertension in Blacks. Am J Hypertens 1997;110:804–812.
   Google Scholar
• Timberlake DS, O’Connor DT, Parmer RJ. Molecular genetics of hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens 2001;10:71–79.
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981–2997.
   PubMed Web of Science ®Google Scholar
• Jamerson K, DeQuattro V. The impact of ethnicity on response to antihypertensive therapy. Am J Med 1996;101:22S–32S.
   PubMedGoogle Scholar
• Saunders E, Weir MR, Kong BW, Hollifield J, Gray J, Vertes V, Sowers JR, Zemel MB, Curry C, Schoenberger J, Wright J, Kirkendall W, Conradi EC, Jenkins P, McLean B, Massie B, Berenson G, Flamenbaum W. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990;150:1707–1713.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 2000;160:825–831.
   PubMed Web of Science ®Google Scholar
• Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG; Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003;163:525–541.
   PubMed Web of Science ®Google Scholar
• Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B.Association of a human β3 subunit variant with hypertension. Nat Genet 1998;18: 45–48.
   PubMed Web of Science ®Google Scholar
• Pietruck, F, Moritz A, Montemurro M, Sell A, Busch S, Rosskopf D, Virchow S, Esche H, Brockmeyer N, Jakobs KH, Siffert W. Selectively enhanced cellular signaling by G proteins in essential hypertension. Gαi2, Gαi3, G β 1 and G β 2 are not mutated. Circ Res 1996;79:974–983.
   PubMed Web of Science ®Google Scholar
• Benjafield A, Jeyasingam C,. Nyholt DR, Griffiths LR, Morris BJ. G-Protein β3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998;32:1094–1097.
   PubMed Web of Science ®Google Scholar
• Beige J, Hohenbleicher H, Distler A, Sharma AY. G-protein β3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999;33:1049–1051.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG. Cappuccio FP. Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 1999;34:1193–1196.
   PubMed Web of Science ®Google Scholar
• Hengstenberg C, Schunkert H, Mayer B, . Association between a polymorphism in the G protein β3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001;49:820–827.
   PubMed Web of Science ®Google Scholar
• Schunkert H, Hense HW, Döring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein β3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998;32:510–513.
   PubMed Web of Science ®Google Scholar
• Hegele RA, Anderson C, Young TK, Connelly PW . G-protein β3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999;9:972–977.
   PubMed Web of Science ®Google Scholar
• Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Heyns ADP, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge JB, Wang YL, Yang DL, Husing J, Rosskopf D. Worldwide ethnic distribution of the G protein β3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals, J Am Soc Nephrol 1999;10:1921–1930.
   PubMed Web of Science ®Google Scholar
• Siffert W, Naber C, Walla M, Ritz E . G protein β3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens 1999;17:1095–1098.
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Peñarroja G, Richart C, Castro A, Vendrell J, Broch M, López-Bermejo A, Ricart W. G protein β3 gene variant, vascular function, and insulin sensitivity in type 2 diabetes. Hypertension 2003;41:124–129.
   PubMed Web of Science ®Google Scholar
• Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D, Luc G, Plouin PF, Tiret L, Cambien F. The 825C/T polymorphism of the G-protein subunit β 3 is not related to hypertension. Hypertension 1999;33:1175–1178.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K, Takami S, Nakata Y, Satoh H, Hisamichi S, Higaki J, Ogihara T. Human G-protein β3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am J Hypertens 2000;13:140–145.
   PubMed Web of Science ®Google Scholar
• Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000;33:1297–1300.
   Google Scholar
• Oshiro Y, Ueda K, Wakasaki H, Takasu N, Nanjo K. Analysis of 825C/T polymorphism of a G protein β3 subunit in obese/diabetic Japanese. Biochem Biophys Res Commun 2001;286:678–680.
   PubMed Web of Science ®Google Scholar
• Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Mol Genet Metab 2005; 86:293–299.
   PubMed Web of Science ®Google Scholar
• Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. G protein β3 subunit variant and essential hypertension in Japanese. Hypertension 1998;32:935–938.
   PubMed Web of Science ®Google Scholar
• Huang X, Ju Z, Song Y, Zhang H, Sun K, Lu H, Yang Z, Jose PA, Zhou G, Wang M, Wang W, Feng S, Hui R. Lack of association between the G protein beta3 subunit gene and essential hypertension in Chinese: a case-control and a family-based study. J Mol Med 2003;81:729–735.
   PubMed Web of Science ®Google Scholar
• Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001;37:739–743.
   PubMed Web of Science ®Google Scholar
• Rosskopf D, Busch S, Manthey I, Siffert W. G protein β3 gene: structure, promoter, and additional polymorphisms. Hypertension 2000;36:33–41.
   PubMed Web of Science ®Google Scholar
• Rosskopf D, Manthey I, Siffert W. Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein β3 subunit. Pharmacogenetics 2002; 12:209–220.
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Rosskopf D, Düsing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension 1993;21:607–617.
   PubMed Web of Science ®Google Scholar
• Iiri T, Bourne H . G proteins propel surprise. Nat Genet 1998;18:8–10.
   PubMed Web of Science ®Google Scholar
• Tuncbilek E, Ozguc M. Application of medical genetics in Turkey. Turk J Pediatr 2007;49:353–359.
   PubMed Web of Science ®Google Scholar
• Morris BJ, Benjafield AV, Lin RCY. Essential hypertension: Genes and dreams. Clin Chem Lab Med 2003;41:834–844.
   PubMed Web of Science ®Google Scholar
• Williams SM, Addy JH, Phillips III JA, Dai M, Kpodonu J, Afful J, Jackson H, Joseph K, Eason F, Murray MM, Epperson P, Aduonum A, Wong LJ, Jose PA, Felder RA. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000;36:2–6.
   PubMed Web of Science ®Google Scholar